Correlation Between Candel Therapeutics and RespireRx Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and RespireRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and RespireRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Candel Therapeutics and RespireRx Pharmaceuticals, you can compare the effects of market volatilities on Candel Therapeutics and RespireRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of RespireRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and RespireRx Pharmaceuticals.

Diversification Opportunities for Candel Therapeutics and RespireRx Pharmaceuticals

-0.77

Correlation Coefficient

Candel Therapeutics  RespireRx Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Candel and RespireRx is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and RespireRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RespireRx Pharmaceuticals and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with RespireRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RespireRx Pharmaceuticals has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and RespireRx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Candel Therapeutics and RespireRx Pharmaceuticals

If you would invest  560.00  in Candel Therapeutics on October 25, 2024 and sell it today you would earn a total of  127.00  from holding Candel Therapeutics or generate 22.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	1.67%
Values	Daily Returns

Candel Therapeutics  vs.  RespireRx Pharmaceuticals

Candel Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Candel Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady fundamental indicators, Candel Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

RespireRx Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RespireRx Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, RespireRx Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Candel Therapeutics and RespireRx Pharmaceuticals

The main advantage of trading using opposite Candel Therapeutics and RespireRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, RespireRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RespireRx Pharmaceuticals will offset losses from the drop in RespireRx Pharmaceuticals' long position.

The idea behind Candel Therapeutics and RespireRx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.